Radial dose function of a 90Sr 90Y seed in water and A150: Comment on Calibration and characterization of beta-particle sources for intravascular brachytherapy

Intravascular brachytherapy with beta sources has become a useful technique to prevent restenosis after cardiovascular intervention. In particular, the Beta-Cath high-dose-rate system, manufactured by Novoste Corporation, is a commercially available 90Sr 90Y source for intravascular brachytherapy that is achieving widespread use. Its dosimetric characterization has attracted considerable attention in recent years. Unfortunately, the short ranges of the emitted beta particles and the associated large dose gradients make experimental measurements particularly difficult. This circumstance has motivated the appearance of a number of papers addressing the characterization of this source by means of Monte Carlo simulation techniques.

Microtubule Associated Protein 1b (MAP1B) Is a Marker of the Microtubular Cytoskeleton in Podocytes but Is Not Essential for the Function of the Kidney Filtration Barrier in Mice.

Podocytes are essential for the function of the kidney glomerular filter. A highly differentiated cytoskeleton is requisite for their integrity. Although much knowledge has been gained on the organization of cortical actin networks in podocyte's foot processes, less is known about the molecular organization of the microtubular cytoskeleton in primary processes and the cell body. To gain an insight into the organization of the microtubular cytoskeleton of the podocyte, we systematically analyzed the expression of microtubule associated proteins (Maps), a family of microtubules interacting proteins with known functions as regulator, scaffold and guidance proteins. We identified microtubule associated protein 1b (MAP1B) to be specifically enriched in podocytes in human and rodent kidney. Using immunogold labeling in electron microscopy, we were able to demonstrate an enrichment of MAP1B in primary processes. A similar association of MAP1B with the microtubule cytoskeleton was detected in cultured podocytes. Subcellular distribution of MAP1B HC and LC1 was analyzed using a double fluorescent reporter MAP1B fusion protein. Subsequently we analyzed mice constitutively depleted of MAP1B. Interestingly, MAP1B KO was not associated with any functional or structural alterations pointing towards a redundancy of MAP proteins in podocytes. In summary, we established MAP1B as a specific marker protein of the podocyte microtubular cytoskeleton.

Quality Function Deployment asiakaslähtöisen tuotekehityksen menetelmänä

Quality Function Deployment eli QFD on menetelmä, jonka avulla asiakkaiden tarpeet huomioidaan systemaattisesti koko tuotekehitysprosessissa. Tuotekehitys on yleensä se osa yrityksen toimintaa, missä asiakaslähtöisyys voidaan parhaiten ottaa huomioon. Työn tarkoituksena on kuvata lukijalle Quality Function Deployment tuotekehitysmenetelmän eri vaiheita ja esitellä mahdollisimman selkeästi menetelmän periaatteet. Menetelmän neljästä vaiheesta paneudutaan etenkin ensimmäiseen eli laadun taloon. Myös menetelmän kolme seuraavaa vaihetta esitellään. Menetelmän toteutus aloitetaan asiakastarpeiden kartoittamisella. Asiakastarpeet ovat menetelmän perusta. Matriisitekniikalla asiakastarpeet muunnetaan tuoteominaisuuksiksi. Matriisia analysoimalla saadaan ne tuoteominaisuudet, joita aletaan mahdollisesti kehittää. Menetelmästä voidaan käyttää vain laadun taloa tai jatkaa seuraaviin vaiheisiin, missä kolmen muun matriisin avulla iskostetaan asiakastarpeet koko organisaatioon, tuotekehitykseen konseptin luomisesta aina valmistukseen asti. Menetelmää voidaan käyttää monella eri toimialalla. valmistukseen asti. Menetelmää voidaan käyttää monella eri toimialalla.

Uromodulin, kidney function, cardiovascular disease, and mortality

Uromodulin (Tamm-Horsfall protein) is exclusively produced by the kidney and is the most abundant protein excreted in normal urine. The level of uromodulin in urine could represent a useful biomarker for renal tubular function. The study of Garimella et al. adds elements into the debate, by suggesting that, in elderly adults, low urinary uromodulin concentrations in spot urine identify people at risk of progressive kidney disease and mortality above and beyond established markers of kidney disease.